Compartir, , Google Plus, Pinterest,

Posted in:

IMI 2. Iniciativa Medicamentos Innovadores

Fecha inicio: 09.07.2015 Fecha límite: 13.10.2015
Importe: 47.4770.000

Topics:

  • Topic 1: Patient perspective elicitation on benefits and risks of medicinal products, from development through the entire life cycle, to inform the decision-making process by regulators and health technology assessment bodies
  • Topic 2: Diabetic kidney disease biomarkers (DKD-BM)
  • Topic 3: Inflammation and AD: modulating microglia function – focussing on TREM2 and CD33
  • Topic 4: Understanding the role of amyloid imaging biomarkers in the current and future diagnosis and management of patients across the spectrum of cognitive impairment (from pre-dementia to dementia)
  • Topic 5: Evolving models of patient engagement and access for earlier identification of Alzheimer’s disease: phased expansion study
  • Topic 6: From ApoE biology to validated Alzheimer’s disease targets

Más información